The role of the quality control system for diagnostics of oncological diseases in radiomics
- Authors: Khoruzhaya A.N.1, Ahkmad E.S.1, Semenov D.S.1
-
Affiliations:
- Moscow Center for Diagnostics and Telemedicine
- Issue: Vol 2, No 2 (2021)
- Pages: 170-184
- Section: Reviews
- URL: https://journals.rcsi.science/DD/article/view/60393
- DOI: https://doi.org/10.17816/DD60393
- ID: 60393
Cite item
Abstract
Modern medical imaging methods allow for both qualitative and quantitative evaluations of tumors and issues surrounding them. Advances in computer science and big data processing are transforming any radiological study into analytic datasets, especially with the use of machine learning in medical image analysis. Among these datasets, statistically significant correlations with clinical events can then be searched for to subsequently assess their predictive value and ability to predict a particular clinical outcome. This concept, known as “radiomics,” was first described in 2012. It is particularly important in oncology because each type of tumor can be subdivided into many different molecular genetic subtypes, and simple visual characteristics are no longer sufficient. Moreover, as an absolutely noninvasive method, radiomics can provide a radiologist with additional information that would otherwise be unavailable without a histological examination of biopsy material. However, as with any methodology based on the use of big data, the question of the quality of the initial data becomes critical, because this can directly affect the outcome of the analysis and provide incorrect diagnostic information.
In this literature review, we examine potential approaches to ensuring the quality of research at all stages, from technical control of the state of diagnostic equipment to the extraction of imaging markers in oncology and the calculation of their correlation with clinical data.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Anna N. Khoruzhaya
Moscow Center for Diagnostics and Telemedicine
Author for correspondence.
Email: a.khoruzhaya@npcmr.ru
ORCID iD: 0000-0003-4857-5404
SPIN-code: 7948-6427
Junior Researcher, Department of Innovative Technologies
Russian Federation, 28-1 Srednyaya Kalitnikovskaya str., 109029, MoscowEkaterina S. Ahkmad
Moscow Center for Diagnostics and Telemedicine
Email: e.ahkmad@npcmr.ru
ORCID iD: 0000-0002-8235-9361
SPIN-code: 5891-4384
Russian Federation, 28-1 Srednyaya Kalitnikovskaya str., 109029, Moscow
Dmitriy S. Semenov
Moscow Center for Diagnostics and Telemedicine
Email: d.semenov@npcmr.ru
ORCID iD: 0000-0002-4293-2514
SPIN-code: 2278-7290
Russian Federation, 28-1 Srednyaya Kalitnikovskaya str., 109029, Moscow
References
- Kumar V, Gu Y, Basu S, et al. Radiomics: The process and the challenges. Magn Reson Imaging. 2012;30(9):1234–1248. doi: 10.1016/j.mri.2012.06.010
- Papanikolaou N, Matos C, Koh DM. How to develop a meaningful radiomic signature for clinical use in oncologic patients. Cancer Imaging. 2020;20(1):33. doi: 10.1186/s40644-020-00311-4
- Aerts HJ, Grossmann P, Tan Y, et al. Defining a radiomic response phenotype: A pilot study using targeted therapy in NSCLC. Sci Rep. 2016;6:33860. doi: 10.1038/srep33860
- Coroller TP, Grossmann P, Hou Y, et al. CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. Radiother Oncol. 2015;114(3):345–350. doi: 10.1016/j.radonc.2015.02.015
- Lopez CJ, Nagornaya N, Parra NA, et al. Association of radiomics and metabolic tumor volumes in radiation treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2017;97(3):586–595. doi: 10.1016/j.ijrobp.2016.11.011
- De Souza NM, Achten E, Alberich-Bayarri A, et al. Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR). Insights Imaging. 2019;10(1):87. doi: 10.1186/s13244-019-0764-0
- Jones EF, Buatti JM, Shu HK, et al. Clinical trial design and development work group within the quantitative imaging network. Tomography. 2020;6(2):60–64. doi: 10.18383/j.tom.2019.00022
- European Society of Radiology (ESR). ESR statement on the validation of imaging biomarkers. Insights Imaging. 2020;11(1):76. doi: 10.1186/s13244-020-00872-9
- Grimm LJ, Zhang J, Mazurowski MA. Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms. J Magn Reson Imaging. 2015;42(4):902–907. doi: 10.1002/jmri.24879
- Nie K, Shi L, Chen Q, et al. Rectal cancer: Assessment of neoadjuvant chemoradiation outcome based on radiomics of multi-parametric MRI. Clin Cancer Res. 2016;22(21):5256–5264. doi: 10.1158/1078-0432.CCR-15-2997
- Kim H, Park CM, Lee M, et al. Impact of reconstruction algorithms on ct radiomic features of pulmonary tumors: analysis of intra- and inter-reader variability and inter-reconstruction algorithm variability. PLoS One. 2016;11(10):e0164924. doi: 10.1371/journal.pone.0164924
- Ohri N, Duan F, Snyder BS, et al. Pretreatment 18F-FDG PET textural features in locally advanced non-small cell lung cancer: Secondary analysis of ACRIN 6668/RTOG 0235. J Nucl Med. 2016; 57(6):842–848. doi: 10.2967/jnumed.115.166934
- Zhang B, Tian J, Dong D, et al. Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma. Clin Cancer Res. 2017;23(15):4259–4269. doi: 10.1158/1078-0432.CCR-16-2910
- Nakatsugawa M, Cheng Z, Goatman KA, et al. Radiomic analysis of salivary glands and its role for predicting xerostomia in irradiated head and neck cancer patients. Int J Radiat Oncol Biol Phys. 2016; 96(2 suppl):S217. doi: 10.1016/j.ijrobp.2016.06.539
- Shafiee MJ, Chung AG, Khalvati F, et al. Discovery radiomics via evolutionary deep radiomic sequencer discovery for pathologically proven lung cancer detection. J Med Imaging. 2016;4(4):041305. doi: 10.1117/1.JMI.4.4.041305
- Echegaray S, Nair V, Kadoch M, et al. A rapid segmentation-insensitive «Digital Biopsy» method for radiomic feature extraction: method and pilot study using ct images of non-small cell lung cancer. Tomography. 2016;2(4):283–294. doi: 10.18383/j.tom.2016.00163
- Li H, Galperin-Aizenberg M, Pryma D, et al. Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy. Radiother Oncol. 2018;129(2):218–226. doi: 10.1016/j.radonc.2018.06.025
- Tajbakhsh N, Shin JY, Gurudu SR, et al. Convolutional neural networks for medical image analysis: full training or fine tuning? IEEE Transactions on Medical Imaging. 2016;35(5):1299–1312. doi: 10.1109/TMI.2016.2535302
- Elguindi S, Zelefsky MJ, Jiang J, et al. Deep learning-based auto-segmentation of targets and organs-at-risk for magnetic resonance imaging only planning of prostate radiotherapy. Phys Imaging Radiat Oncol. 2019;12:80–86. doi: 10.1016/j.phro.2019.11.006
- Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563–577. doi: 10.1148/radiol.2015151169
- Buckler AJ, Bresolin L, Dunnick NR, et al. Quantitative imaging test approval and biomarker qualification: Interrelated but distinct activities. Radiology. 2011;259(3):875–884. doi: 10.1148/radiol.10100800
- Alobaidli S, McQuaid S, South C, et al. The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning. Br J Radiol. 2014;87(1042):20140369. doi: 10.1259/bjr.20140369
- Li H, Giger ML, Lan L, et al. Comparative analysis of image-based phenotypes of mammographic density and parenchymal patterns in distinguishing between BRCA1/2 cases, unilateral cancer cases, and controls. J Med Imaging. 2014;1(3):031009. doi: 10.1117/1.JMI.1.3.031009
- Goh V, Ganeshan B, Nathan P, et al. Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology. 2011;261(1):165–171. doi: 10.1148/radiol.11110264
- Yip C, Davnall F, Kozarski R, et al. Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. Dis Esophagus. 2015;28(2):172–179. doi: 10.1111/dote.12170
- Park JE, Kim HS. Radiomics as a quantitative imaging biomarker: practical considerations and the current standpoint in neuro-oncologic studies. Nucl Med Mol Imaging. 2018;52(2):99–108. doi: 10.1007/s13139-017-0512-7
- Sergunova KA, Akhmad ES, Semenov DS, et al. Medical physicist’s participation in quality assurance and safety in magnetic resonance imaging. Medical physics. 2020;(3):78–85. (In Russ).
- Clements JB, Baird CT, de Boer SF, et al. AAPM medical physics practice guideline 10.a.: Scope of practice for clinical medical physics. J Appl Clin Med Phys. 2018;19(6):11–25. doi: 10.1002/acm2.12469
- Shukla-Dave A, Obuchowski NA, Chenevert TL, et al. Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging. 2019;49(7):e101–e121. doi: 10.1002/jmri.26518
- Russek SE, Boss M, Jackson EF, et al. Characterization of NIST/ISMRM MRI System Phantom. Proc Intl Soc Mag Reson Med. 2012;20:2456.
- Kuo MD, Jamshidi N. Behind the numbers: Decoding molecular phenotypes with radiogenomics –guiding principles and technical considerations. Radiology. 2014;270(2):320–325. doi: 10.1148/radiol.13132195
- Narang S, Lehrer M, Yang D, et al. Radiomics in glioblastoma: current status, challenges and potential opportunities. Transl Cancer Res. 2016;5(4):383–397. doi: 10.21037/tcr.2016.06.31
- O’Connor JP, Aboagye EO, Adams JE, et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017;14(3):169–186. doi: 10.1038/nrclinonc.2016.162
- Buizza G, Toma-Dasu I, Lazzeroni M, et al. Early tumor response prediction for lung cancer patients using novel longitudinal pattern features from sequential PET/CT image scans. Phys Med. 2018;54:21–29. doi: 10.1016/j.ejmp.2018.09.003
- Raunig DL, McShane LM, Pennello G, et al. Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment. Stat Methods Med Res. 2015;24(1):27–67. doi: 10.1177/0962280214537344
- Obuchowski NA, Reeves AP, Huang EP, et al. Quantitative imaging biomarkers: a review of statistical methods for computer algorithm comparisons. Stat Methods Med Res. 2015;24(1):68–106. doi: 10.1177/0962280214537390
- Elguindi S, Zelefsky MJ, Jiang J, et al. Deep learning-based auto-segmentation of targets and organs-at-risk for magnetic resonance imaging only planning of prostate radiotherapy. Phys Imaging Radiat Oncol. 2019;12:80–86. doi: 10.1016/j.phro.2019.11.006
- Morozov SP, Vladzimirsky AV, Klyashtorny VG, et al. Clinical trials of software based on intelligent technologies (radiation diagnostics). Methodological recommendations. Moscow; 2019. 33 p. (In Russ).
- Sullivan DC, Obuchowski NA, Kessler LG, et al. Metrology standards for quantitative imaging biomarkers. Radiology. 2015;277(3):813–825. doi: 10.1148/radiol.2015142202
- Shur J, Blackledge M, D’Arcy J, et al. MRI texture feature repeatability and image acquisition factor robustness, a phantom study and in silico study. Eur Radiol Exp. 2021;5(1):2. doi: 10.1186/s41747-020-00199-6
- Bane O, Hectors SJ, Wagner M, et al. Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI: Results from a multicenter phantom study. Magn Reson Med. 2018;79(5):2564–2575. doi: 10.1002/mrm.26903
- He Y, Liu Y, Dyer BA, et al. 3D-printed breast phantom for multi-purpose and multi-modality imaging. Quant Imaging Med Surg. 2019;9(1):63–74. doi: 10.21037/qims.2019.01.05
- Scheuermann JS, Reddin JS, Opanowski A, et al. Qualification of national cancer institute-designated cancer centers for quantitative PET/CT imaging in clinical trials. J Nucl Med. 2017;58(7):1065–1071. doi: 10.2967/jnumed.116.186759
- Obuchowski NA, Barnhart HX, Buckler AJ, et al. Statistical issues in the comparison of quantitative imaging biomarker algorithms using pulmonary nodule volume as an example. Stat Methods Med Res. 2015;24(1):107–140. doi: 10.1177/0962280214537392
- Kessler LG, Barnhart HX, Buckler AJ, et al. The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions. Stat Methods Med Res. 2015;24(1):9–26. doi: 10.1177/0962280214537333
- Napel S, Mu W, Jardim-Perassi BV, et al. Quantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats. Cancer. 2018;124(24):4633–4649. doi: 10.1002/cncr.31630
- Rozhkova NI, Bozhenko VK, Burdina II, et al. Radiogenomics of breast cancer as new vector of interdisciplinary integration of radiation and molecular biological technologies (literature review). Medical alphabet. 2020;(20):21–29. (In Russ). doi: 10.33667/2078-5631-2020-20-21-29
- Antropova N, Huynh BQ, Giger ML. A deep feature fusion methodology for breast cancer diagnosis demonstrated on three imaging modality datasets. Med Phys. 2017;44(10):5162–5171. doi: 10.1002/mp.12453
- Antunovic L, Gallivanone F, Sollini M, et al. [18F]FDG PET/CT features for the molecular characterization of primary breast tumors. Eur J Nucl Med Mol Imaging. 2017;44(12):1945–1954. doi: 10.1007/s00259-017-3770-9
- Ha S, Park S, Bang JI, et al. Metabolic radiomics for pretreatment 18F-FDG PET/CT to characterize locally advanced breast cancer: histopathologic characteristics, response to neoadjuvant chemotherapy, and prognosis. Sci Rep. 2017;7(1):1556. doi: 10.1038/s41598-017-01524-7
- Guo W, Li H, Zhu Y, et al. Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data. J Med Imaging (Bellingham). 2015;2(4):041007. doi: 10.1117/1.JMI.2.4.041007
- Saha A, Harowicz MR, Grimm LJ, et al. A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features. Br J Cancer. 2018;119(4):508–516. doi: 10.1038/s41416-018-0185-8
- Dong Y, Feng Q, Yang W, et al. Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI. Eur Radiol. 2018;28(2):582–591. doi: 10.1007/s00330-017-5005-7
- Chan HM, van der Velden BH, Loo CE, Gilhuijs KG. Eigentumors for prediction of treatment failure in patients with early-stage breast cancer using dynamic contrast-enhanced MRI: a feasibility study. Phys Med Biol. 2017;62(16):6467–6485. doi: 10.1088/1361-6560/aa7dc5
- Braman NM, Etesami M, Prasanna P, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res. 2017;19(1):57. doi: 10.1186/s13058-017-0846-1
- Chamming’s F, Ueno Y, Ferré R, et al. Features from computerized texture analysis of breast cancers at pretreatment MR imaging are associated with response to neoadjuvant chemotherapy. Radiology. 2018;286(2):412–420. doi: 10.1148/radiol.2017170143
- Partridge SC, Zhang Z, Newitt DC, et al. Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: the ACRIN 6698 multicenter trial. Radiology. 2018;289(3):618–627. doi: 10.1148/radiol.2018180273
- Park H, Lim Y, Ko ES, et al. Radiomics signature on magnetic resonance imaging: association with disease-free survival in patients with invasive breast cancer. Clin Cancer Res. 2018;24(19):4705–4714. doi: 10.1158/1078-0432.CCR-17-3783
- Nasrullah N, Sang J, Alam MS, et al. Automated lung nodule detection and classification using deep learning combined with multiple strategies. Sensors (Basel). 2019;19(17):3722. doi: 10.3390/s19173722
- Carter BW, Godoy MC, Erasmus JJ. Predicting malignant nodules from screening CTs. J Thorac Oncol. 2016;11(12):2045–2047. doi: 10.1016/j.jtho.2016.09.117
- Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006. doi: 10.1038/ncomms5006
- Zhou H, Dong D, Chen B, et al. Diagnosis of distant metastasis of lung cancer: based on clinical and radiomic features. Transl Oncol. 2018;11(1):31–36. doi: 10.1016/j.tranon.2017.10.010
- Liu Y, Kim J, Balagurunathan Y, et al. Radiomic features are associated with EGFR mutation status in lung adenocarcinomas. Clin Lung Cancer. 2016;17(5):441–448.e6. doi: 10.1016/j.cllc.2016.02.001
- Fave X, Zhang L, Yang J, et al. Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer. Sci Rep. 2017;7(1):588. doi: 10.1038/s41598-017-00665-z
- Coroller TP, Agrawal V, Narayan V, et al. Radiomic phenotype features predict pathological response in non-small cell lung cancer. Radiother Oncol. 2016;119(3):480–486. doi: 10.1016/j.radonc.2016.04.004
- Kickingereder P, Neuberger U, Bonekamp D, et al. Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma. Neuro Oncol. 2018;20(6):848–857. doi: 10.1093/neuonc/nox188
- Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA, et al. Tumor surface regularity at MR imaging predicts survival and response to surgery in patients with glioblastoma. Radiology. 2018;288(1):218–225. doi: 10.1148/radiol.2018171051
- Zhou Z, Chen L, Sher D, et al. Predicting lymph node metastasis in head and neck cancer by combining many-objective radiomics and 3-dimensioal convolutional neural network through evidential reasoning. Annu Int Conf IEEE Eng Med Biol Soc. 2018;2018:1–4. doi: 10.1109/EMBC.2018.8513070
- Wang G, He L, Yuan C, et al. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma. Eur J Radiol. 2018;98:100–106. doi: 10.1016/j.ejrad.2017.11.007
- Chen X, Oshima K, Schott D, et al. Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study. PLoS One. 2017;12:e0178961. doi: 10.1371/journal.pone.0178961
- Huang YQ, Liang CH, He L, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157–2164. doi: 10.1200/JCO.2015.65.9128
- Lin YC, Lin G, Hong JH, et al. Diffusion radiomics analysis of intratumoral heterogeneity in a murine prostate cancer model following radiotherapy: Pixelwise correlation with histology. J Magn Reson Imaging. 2017;46(2):483–489. doi: 10.1002/jmri.25583
- Chaddad A, Kucharczyk MJ, Niazi T. Multimodal radiomic features for the predicting gleason score of prostate cancer. Cancers (Basel). 2018;10(8):249. doi: 10.3390/cancers10080249
- Ognerubov NA, Shatov IA, Shatov AV. Radiogenomics and radiomics in the diagnostics of malignant tumours: a literary review. Tambov University Reports. Series: Natural and Technical Sciences. 2017;22(6):1453–1460. (In Russ). doi: 10.20310/1810-0198-2017-22-6-1453-1460.